Clinical Trial Update: Progenitor Cell Therapy in Dilative Cardiomyopathy [Phase 1, Phase 2]

View source ↗

Summary

The update indicates that Phase 1 and Phase 2 trials of progenitor cell therapy for dilated cardiomyopathy presenting as heart failure have completed. No trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Heart Failure, Congestive, Cardiomyopathy, Dilated | Phase 1, Phase 2 | Status: COMPLETED